ライフサイエンスコーパス: deficiency disease

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ty the enzyme may be used to treat ADS lyase deficiency disease.

2 MyD88 offered partial protection from Foxp3 deficiency disease.

3 ) in organ culture and animal models of bone-deficiency disease.

4 selective neural vulnerability in DNA repair deficiency disease.

5 ted a variety of vitamin D insufficiency and deficiency diseases.

6 n the treatment for obesity-related vascular deficiency diseases.

7 utritional requirement in humans is the zinc deficiency disease, acrodermatitis enteropathica.

8 ve therapeutic relevance for the human SSADH deficiency disease and GHB overdose and toxicity.

9 an innovative therapy for correcting genetic deficiency diseases and augmenting immune function.

10 provide mechanistic insight into telomerase-deficiency diseases and encourage the development of gen

11 s, prevention and treatment of micronutrient deficiency diseases, and nutritional support for at-risk

12 Nutrient deficiency diseases are giving way to energy imbalances,

13 Primary immune deficiency diseases arise due to heritable defects that

14 rrelate with increased propensity for energy deficiency diseases as well as longevity.

15 crobial signals in the pathogenesis of Foxp3 deficiency disease by studying Foxp3 mutant mice that ha

16 in activity observed in a child with a CPTII deficiency disease, establishes that Glu(487) is crucial

17 reviously unidentified family of ganglioside deficiency diseases exist.

18 Here we describe a deficiency disease in two human siblings that presented

19 enefit patients suffering from other hormone deficiency diseases including liver disease and Parkinso

20 mmune responses to the pathogenesis of Foxp3 deficiency disease is unknown.

21 The etiology of most pediatric hormone deficiency diseases is poorly understood.

22 titrypsin (AAT) variants responsible for AAT deficiency disease: null Hong Kong (NHK) and Z allele.

23 Imbalances in our food can lead to deficiency diseases or obesity and associated metabolic

24 The most severe primary immune deficiency diseases (PIDs) have been successfully treate

25 ers studying therapy for rare primary immune deficiency diseases (PIDs), including severe combined im

26 Monogenic deficiency diseases provide unique opportunities to defi

27 new, cell type-selective leukocyte adhesion deficiency disease, providing new insights into CF patho

28 a mean requirement of 46 mg/d to prevent the deficiency disease scurvy.

29 are potential drug targets for thioesterase deficiency diseases such as INCL.

30 ces in time course of murine and human RPE65-deficiency diseases suggests that preclinical efficacy t

31 The shift from acute infectious and deficiency diseases to chronic noncommunicable diseases

32 to cold climates and contributing to "energy deficiency" diseases today.

33 For many years, severe combined immune deficiency diseases, which are characterized by virtual

34 ton's tyrosine kinase (btk) cause the B cell deficiency diseases X-linked agammaglobulinemia (XLA) in

35 Moreover, DDB2 is mutated in the repair-deficiency disease xeroderma pigmentosum (Group E).

36 tected in patients suffering from the repair deficiency disease xeroderma pigmentosum (group E).

37 ng protein DDB has been linked to the repair deficiency disease xeroderma pigmentosum group E (XP-E),

38 repair, and it has been linked to the repair deficiency disease xeroderma pigmentosum.

39 e proved to be good models for the human NER deficiency disease, xeroderma pigmentosum, leading to sp

40 E2F1-activated transcription and the repair deficiency disease XP-E.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。